Together, our data would be consistent with a previous report of TGF-β induced SMAD signaling in hepatoma cells (Buenemann et al, 2001), and the potential for upstream regulation of TGF-β by Stat5 (Hosui et al, 2009). The gene discussed is STAT5B; the disease is hepatocellular carcinoma.